Yifan Kong

1.9k total citations
53 papers, 996 citations indexed

About

Yifan Kong is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Materials Chemistry. According to data from OpenAlex, Yifan Kong has authored 53 papers receiving a total of 996 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 13 papers in Pulmonary and Respiratory Medicine and 9 papers in Materials Chemistry. Recurrent topics in Yifan Kong's work include Prostate Cancer Treatment and Research (11 papers), Microtubule and mitosis dynamics (6 papers) and Cancer-related gene regulation (5 papers). Yifan Kong is often cited by papers focused on Prostate Cancer Treatment and Research (11 papers), Microtubule and mitosis dynamics (6 papers) and Cancer-related gene regulation (5 papers). Yifan Kong collaborates with scholars based in China, United States and Australia. Yifan Kong's co-authors include Xiaoqi Liu, Nihal Ahmad, Lijun Cheng, Yanquan Zhang, Zhuangzhuang Zhang, Zhiguo Li, Fengyi Mao, Elia Farah, Lang Li and Ruixin Wang and has published in prestigious journals such as Journal of Biological Chemistry, Renewable and Sustainable Energy Reviews and Molecular and Cellular Biology.

In The Last Decade

Yifan Kong

49 papers receiving 986 citations

Peers

Yifan Kong

PRM

ONCOL

Chunmeng Wang China

Yong‐Xia Wang China

Raúl Cassia Argentina

Jiayi Cao China

Xuan Gao China

Xiaofang Zhang China

Donglin Liu China

Hua Zhong China

Nur P. Damayanti United States

Yunxue Li China

Chunmeng Wang China

Yifan Kong

526 ×1.0

290 ×1.4

PRM

255 ×1.4

ONCOL

283 ×1.6

70 ×0.6

Citations per year, relative to Yifan Kong Yifan Kong (= 1×) peers Chunmeng Wang

Countries citing papers authored by Yifan Kong

Since Specialization

Citations

This map shows the geographic impact of Yifan Kong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yifan Kong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yifan Kong more than expected).

Fields of papers citing papers by Yifan Kong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yifan Kong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yifan Kong. The network helps show where Yifan Kong may publish in the future.

Co-authorship network of co-authors of Yifan Kong

This figure shows the co-authorship network connecting the top 25 collaborators of Yifan Kong. A scholar is included among the top collaborators of Yifan Kong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yifan Kong. Yifan Kong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Zhiguo, Xiongjian Rao, Derek B. Allison, et al.. (2025). PLK1-mediated PDHA1 phosphorylation drives mitochondrial dysfunction, mitophagy, and cancer progression in Cr(VI)-associated lung cancer. Journal of Biological Chemistry. 301(7). 110406–110406. 2 indexed citations

Zhang, Yanquan, Jinghui Liu, Daheng He, et al.. (2025). The kinase PLK1 promotes Hedgehog signaling–dependent resistance to the antiandrogen enzalutamide in metastatic prostate cancer. Science Signaling. 18(878). eadi5174–eadi5174. 5 indexed citations

Qin, Yi‐Xian, et al.. (2025). Advanced fault detection, diagnosis and prognosis in HVAC systems: Lifecycle insight, key challenges, and promising approaches. Renewable and Sustainable Energy Reviews. 219. 115867–115867. 4 indexed citations

Lin, Jiawei, Yifan Kong, Dongrui R. Lu, et al.. (2025). Explainable machine learning model for predicting the transarterial chemoembolization response and subtypes of hepatocellular carcinoma patients. BMC Gastroenterology. 25(1). 503–503.

Kong, Yifan, Jinpeng Liu, Sai Wu, et al.. (2024). Single-cell analysis identifies PLK1 as a driver of immunosuppressive tumor microenvironment in LUAD. PLoS Genetics. 20(6). e1011309–e1011309. 6 indexed citations

Lin, Jiawei, Jie Li, Yifan Kong, et al.. (2024). Construction of a prognostic model for hepatocellular carcinoma patients receiving transarterial chemoembolization treatment based on the Tumor Burden Score. BMC Cancer. 24(1). 306–306. 4 indexed citations

Tang, Zheng, Yifan Kong, Xiaoqian Chen, et al.. (2023). Performance and degradation pathway of florfenicol antibiotic by nitrogen-doped biochar supported zero-valent iron and zero-valent copper: A combined experimental and DFT study. Journal of Hazardous Materials. 459. 132172–132172. 24 indexed citations

Zhang, Zhuangzhuang, Lijun Cheng, Yifan Kong, et al.. (2021). Co‐Targeting Plk1 and DNMT3a in Advanced Prostate Cancer. Advanced Science. 8(13). e2101458–e2101458. 13 indexed citations

Zhang, Yanquan, Yifan Kong, Elia Farah, et al.. (2021). Epigenetics in prostate cancer treatment. PubMed. 5. 341–356. 11 indexed citations

10.

Kong, Yifan, Yanquan Zhang, Fengyi Mao, et al.. (2020). Inhibition of EZH2 Enhances the Antitumor Efficacy of Metformin in Prostate Cancer. Molecular Cancer Therapeutics. 19(12). 2490–2501. 18 indexed citations

11.

Xun, Xiaogang, Jie Cheng, Yangping Li, et al.. (2019). Solute carriers in scallop genome: Gene expansion and expression regulation after exposure to toxic dinoflagellate. Chemosphere. 241. 124968–124968. 22 indexed citations

12.

Bai, Yunfeng, Zhuangzhuang Zhang, Lijun Cheng, et al.. (2019). Inhibition of enhancer of zeste homolog 2 (EZH2) overcomes enzalutamide resistance in castration-resistant prostate cancer. Journal of Biological Chemistry. 294(25). 9911–9923. 59 indexed citations

13.

Farah, Elia, Chaohao Li, Lijun Cheng, et al.. (2019). NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells. Journal of Biological Chemistry. 294(21). 8543–8554. 50 indexed citations

14.

Li, Zhiguo, Yifan Kong, Qian Luo, et al.. (2018). Plk1-Mediated Phosphorylation of TSC1 Enhances the Efficacy of Rapamycin. Cancer Research. 78(11). 2864–2875. 15 indexed citations

15.

Mao, Fengyi, Jie Li, Qian Luo, et al.. (2018). Plk1 Inhibition Enhances the Efficacy of BET Epigenetic Reader Blockade in Castration-Resistant Prostate Cancer. Molecular Cancer Therapeutics. 17(7). 1554–1565. 34 indexed citations

16.

Kong, Yifan, Lijun Cheng, Fengyi Mao, et al.. (2018). Inhibition of cholesterol biosynthesis overcomes enzalutamide resistance in castration-resistant prostate cancer (CRPC). Journal of Biological Chemistry. 293(37). 14328–14341. 86 indexed citations

17.

Li, Jie, Ruixin Wang, Yifan Kong, et al.. (2017). Targeting Plk1 to Enhance Efficacy of Olaparib in Castration-Resistant Prostate Cancer. Molecular Cancer Therapeutics. 16(3). 469–479. 43 indexed citations

18.

Li, Zhiguo, Jie Li, Yifan Kong, et al.. (2017). Plk1 Phosphorylation of Mre11 Antagonizes the DNA Damage Response. Cancer Research. 77(12). 3169–3180. 48 indexed citations

19.

Li, Zhiguo, Jinghui Liu, Jie Li, et al.. (2017). Polo-like kinase 1 (Plk1) overexpression enhances ionizing radiation-induced cancer formation in mice. Journal of Biological Chemistry. 292(42). 17461–17472. 24 indexed citations

20.

Cheng, Jie, Xiaogang Xun, Yifan Kong, et al.. (2016). Hsp70 gene expansions in the scallop Patinopecten yessoensis and their expression regulation after exposure to the toxic dinoflagellate Alexandrium catenella. Fish & Shellfish Immunology. 58. 266–273. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact